Bolus dose of hydroxycitric acid with glycerol
A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b.i.d. or t.i.d.) using current delivery modalities. The method reduces the rate of occurrence of common adverse events with hydroxycitric acid salts, and reduces the occurrence of reverse effects on diets high in fat and/or alcohol. The method improves the uptake of the active compound thereby reducing the dose required.
1. A sealed dosage container, comprising:
an aqueous solution of a hydroxycitrate salt and glycerol,
wherein the hydroxycitrate salt is a salt of a (−)-hydroxycitric acid selected from the group consisting of sodium, potassium, potassium-magnesium, magnesium hydroxycitrate, double salts based on the counter ions magnesium, potassium and sodium, triple-metal salts based on the counter ions magnesium, potassium and sodium, and combinations thereof, present in a therapeutically effective amount sufficient to suppress appetite of a human in need thereof;
wherein the liquid sealed dosage is prepared by a process comprising:
mixing glycerol and purified water together, wherein the glycerol is present in an amount of about 1 to 3 parts by volume and the purified water is present in an amount of about 3 to 1 parts by volume to create a glycerol and purified water solution; and
dissolving the hydroxycitrate salt in the glycerol and purified water solution to obtain an hydroxycitrate salt concentration ranging from about 1.1 to 1.7 molar dosage.
2. The sealed dosage container of claim 1 , wherein the hydroxycitrate salt is a stable hydroxycitrate salt.
3. The sealed dosage container of claim 1 , wherein the hydroxycitrate salt is a potassium-magnesium salt of (−)-hydroxycitric acid.
4. The sealed dosage container of claim 1 ,
wherein the hydroxycitrate salt is a sodium salt,
wherein the glycerol is completely dissolved in the water before the hydroxycitrate salt is dissolved therein, and
wherein the aqueous solution is substantially free of lactones of the hydroxycitrate salt.
5. The sealed dosage container of claim 1 , wherein the hydroxycitrate salt is present in the sealed container in amount of 3.0 g to 4.5 g±20%, and the glycerol is present in the container in an amount in a range of from 1.0 g to 4.0 g±20%.